XW013W5
Introduction of Caplacizumab into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 5
Introduce Caplacizumab in Subcu, Perc, New Tech 5
Axis Breakdown
Every ICD-10-PCS code is exactly seven characters, one per axis. Each character's meaning is defined by its position in the code.
| Position | Value | Meaning |
|---|---|---|
| 1 | SectionX | New Technology |
| 2 | Body SystemW | Anatomical Regions |
| 3 | Root Operation0 | Introduction Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products |
| 4 | Body Part1 | Subcutaneous Tissue |
| 5 | Approach3 | Percutaneous |
| 6 | Device / Substance / TechnologyW | Caplacizumab |
| 7 | New Technology Group5 | New Technology Group 5 |
Contextual Map
Every relationship of XW013W5 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.
PCS table
- XW0[PCS table]
- [object Object] — Section: [object Object] [Section]: “[object Object]”
- [object Object] — Body System: [object Object] [Body System]: “[object Object]”
- [object Object] — Operation: [object Object] [Operation]: “[object Object]”
Nearest codes
- XW013F5 — Introduction of Other New Technology Therapeutic Substance into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 5 [One axis away]
- XW013W7 — Introduction of COVID-19 Vaccine Booster into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 7 [One axis away]
- XW033W5 — Introduction of Caplacizumab into Peripheral Vein, Percutaneous Approach, New Technology Group 5 [One axis away]
- XW043W5 — Introduction of Caplacizumab into Central Vein, Percutaneous Approach, New Technology Group 5 [One axis away]
Change history
No changes recorded for this code — unchanged since the FY2026 (April) baseline of the change ledger.